These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27328830)

  • 21. Response to the Letter by Middlebeek and Veuger.
    Bellanger M; Demeneix B; Grandjean P; Zoeller RT; Trasande L
    J Clin Endocrinol Metab; 2015 Jun; 100(6):L54-5. PubMed ID: 26047085
    [No Abstract]   [Full Text] [Related]  

  • 22. Implications of research on endocrine disruption for the environmental risk assessment, regulation and monitoring of chemicals in the European Union.
    Matthiessen P; Johnson I
    Environ Pollut; 2007 Mar; 146(1):9-18. PubMed ID: 16996184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dekant W; Kehrer JP
    Toxicol Lett; 2013 Nov; 223(2):A1-4. PubMed ID: 23916789
    [No Abstract]   [Full Text] [Related]  

  • 24. Science based guidance for the assessment of endocrine disrupting properties of chemicals.
    Bars R; Broeckaert F; Fegert I; Gross M; Hallmark N; Kedwards T; Lewis D; O'Hagan S; Panter GH; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):37-46. PubMed ID: 20858523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refinement of the ECETOC approach to identify endocrine disrupting properties of chemicals in ecotoxicology.
    Weltje L; Wheeler JR; Weyers A; Galay-Burgos M
    Toxicol Lett; 2013 Dec; 223(3):291-4. PubMed ID: 23467018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Batta Gori G; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Wallace Hayes A; Gooderham N; Harvey A
    ALTEX; 2013; 30(3):381-5. PubMed ID: 23861084
    [No Abstract]   [Full Text] [Related]  

  • 27. The EU chemicals strategy for sustainability: critical reflections on proposed regulatory changes for endocrine disruptors and mixture toxicity.
    Batke M; Damm G; Foth H; Freyberger A; Gebel T; Gundert-Remy U; Hengstler J; Mangerich A; Partosch F; Röhl C; Schupp T; Wollin KM
    Arch Toxicol; 2022 Apr; 96(4):1133-1135. PubMed ID: 35122513
    [No Abstract]   [Full Text] [Related]  

  • 28. Endocrine disruptors: Revisiting concepts and dogma in toxicology.
    Barouki R
    C R Biol; 2017; 340(9-10):410-413. PubMed ID: 29126513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of mercury on the endocrine system.
    Minoia C; Ronchi A; Pigatto P; Guzzi G
    Crit Rev Toxicol; 2009; 39(7):627. PubMed ID: 19650721
    [No Abstract]   [Full Text] [Related]  

  • 30. Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement.
    Solecki R; Kortenkamp A; Bergman Å; Chahoud I; Degen GH; Dietrich D; Greim H; Håkansson H; Hass U; Husoy T; Jacobs M; Jobling S; Mantovani A; Marx-Stoelting P; Piersma A; Ritz V; Slama R; Stahlmann R; van den Berg M; Zoeller RT; Boobis AR
    Arch Toxicol; 2017 Feb; 91(2):1001-1006. PubMed ID: 27714423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union.
    Beronius A; Rudén C; Hanberg A; Håkansson H
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):111-22. PubMed ID: 19500631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union.
    Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1245-55. PubMed ID: 25742516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward less confusing terminology in endocrine disruptor research.
    Foster WG; Agzarian J
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):152-61. PubMed ID: 18368550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Principles of Pharmacology and Toxicology Also Govern Effects of Chemicals on the Endocrine System.
    Autrup H; Barile FA; Blaauboer BJ; Degen GH; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler JG; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Vermeulen NP
    Toxicol Sci; 2015 Jul; 146(1):11-5. PubMed ID: 26026993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open letter: draft regulation on endocrine-active chemicals.
    Dietrich DR
    Arch Toxicol; 2013 Oct; 87(10):1869-72. PubMed ID: 24048414
    [No Abstract]   [Full Text] [Related]  

  • 36. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; Aulock Sv; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen O; Lang F; Barile FA; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Chem Biol Interact; 2013 Sep; 205(1):A1-5. PubMed ID: 23832050
    [No Abstract]   [Full Text] [Related]  

  • 37. Science and regulation. New science for chemicals policy.
    Schwarzman MR; Wilson MP
    Science; 2009 Nov; 326(5956):1065-6. PubMed ID: 19965413
    [No Abstract]   [Full Text] [Related]  

  • 38. A CASCADE of effects of bisphenol A.
    Bondesson M; Jönsson J; Pongratz I; Olea N; Cravedi JP; Zalko D; Håkansson H; Halldin K; Di Lorenzo D; Behl C; Manthey D; Balaguer P; Demeneix B; Fini JB; Laudet V; Gustafsson JA
    Reprod Toxicol; 2009 Dec; 28(4):563-7. PubMed ID: 19577634
    [No Abstract]   [Full Text] [Related]  

  • 39. [Endocrine disruptors: literature review on toxicology and application field in occupational medicine].
    Borrelli I
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):526-8. PubMed ID: 18409812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
    Bellanger M; Demeneix B; Grandjean P; Zoeller RT; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1256-66. PubMed ID: 25742515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.